ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

124
Analysis
Health Care β€’ Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
β€’24 Jul 2025 21:48

Quiddity Leaderboard T50/​​​100 Sep25: Tung Ho Steel TDIV Deletion Gets Closer than Before

Tung Ho Steel (2006 TT) will need to underperform other names by 13% to be an unconditional T100 DEL and get deleted from TDIV. However, there are...

Share
bullishβ€’Quantitative Analysis
β€’14 Jul 2025 07:05

TWSE Short Interest Weekly (Jul 11th): Unimicron Technology, Zhen Ding Technology, Ase Industrial

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Unimicron Technology, Zhen Ding Technology, Ase...

Logo
392 Views
Share
β€’26 Jun 2025 22:18

Quiddity Leaderboard T50/​​​100 Sep25: Shin Kong Replacement + One Dark Horse TDIV Potential DEL

T100 and TDIV member Tung Ho Steel (2006 TT) is ranked 157th in the T100 selection process and could get deleted from T100 and TDIV if it...

Share
bullishβ€’Quantitative Analysis
β€’16 Jun 2025 07:10

TWSE Foreign Holding Weekly (Jun 13th): TSMC, Mediatek, Asia Vital Components

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC (2330 TT), Mediatek (2454 TT), Asia Vital...

Logo
626 Views
Share
bullishβ€’Pharmaessentia Corp
β€’06 Jun 2025 01:17

Pharmaessentia Corp (6446 TT): Strong Start of 2025; Growth Momentum to Continue

​Pharmaessentia achieves record-high revenue and profits in 1Q25 on strong global uptake of Besremi. Potential BLA submission for ET and Besremi...

Logo
716 Views
Share
x